Introduction {#S1}
============

B cells represent approximately 0.3% of the thymic cellularity. Although their absolute number may, in fact, exceed that of thymic dendritic cells, their role a APCs for central tolerance induction is not well understood, and thymic B cells have often been regarded as "innocent bystanders." Recent data suggest that this view may need to be revised. Here, we will provide a short overview of novel insights into distinct features of thymic B cells and how these may predispose thymic B cells to support T cell tolerance.

The Origin of Thymic B Cells {#S2}
============================

Intrathymic B cell development {#S2-1}
------------------------------

The early thymic progenitor (ETP), i.e., the cell type that gives rise to the T cell lineage, retains some B cell potential ([@B1]). Notch signaling is essential for T lineage specification in ETPs, so that precursors lacking Notch-1 fail to generate T lineage cells in the thymus. There are increased numbers of B cells in the thymus of conditional Notch-1 knockout mice ([@B2]), and this was interpreted to indicate that in the absence of Notch signaling, ETPs undergo B cell differentiation as a "default cell fate" ([@B3], [@B4]). However, subsequent experiments argued that most of the accumulation of thymic B cells under these conditions is not a cell intrinsic effect of Notch-deficiency, but may stem from immigration of peripheral B cells as a result of excessive niche availability ([@B5]). This notion is supported by the observation that perturbations in T cell differentiation downstream of the loss of B lineage potential result in effects on thymic B cell numbers that are reciprocal to their effects on T cell numbers. Specifically, TCRβ^−/−^ mice, in which T cell development is blocked prior to pre-TCR expression, harbor a drastically diminished overall T cell compartment (arrested at the DN3 stage), yet have a 10-fold increase in thymic B cell numbers, whereas TCRα^−/−^ mice, in which T cell differentiation is arrested at the DP stage, display slightly decreased numbers of B cells in the thymus ([@B6], [@B7]).

Does intrathymic B cell differentiation occur under non-perturbed *steady state* conditions? There were early reports on the existence of cells within the thymus whose phenotype -- surface (s)IgM^−^B220^+^CD43^+^ -- resembled that of B cell progenitors in the bone marrow (BM). When these cells were purified and injected intrathymically (i.t.), they gave rise to mature B cells within the thymus ([@B8]). Akashi et al. estimated that concomitant to the release of about 1 × 10^6^ T cells, the thymus also exports around 3 × 10^4^ B cells each day ([@B6]). In sum, there is good evidence that part of the thymic B cell population arises through differentiation within the thymus.

Immigration of peripheral B cells {#S2-2}
---------------------------------

Using more conclusive surface marker combinations, we recently revisited the issue whether the thymus harbors significant numbers of B cell precursors ([@B9]). Among CD19^+^IgM^−^IgD^−^BM cells, pre- and pro-B cells are commonly identified as CD2^+^c-Kit^−^ and CD2^−^c-Kit^+^ cells, respectively. We found that around one-third of thymic CD19^+^ cells were surface IgM^−^IgD^−^, and thereby resembled B cell precursors in the BM. However, pro-B cells (CD19^+^IgM^−^IgD^−^CD2^−^c-Kit^+^) were essentially undetectable in the thymus. Moreover, most thymic CD19^+^IgM^−^IgD^−^CD2^+^c-Kit^−^ cells expressed surface sIgG. Thus, the majority of CD19^+^IgM^−^IgD^−^cells in the thymus (unlike their phenotypic counterparts in the BM) are class-switched mature B cells and not B cell precursors. Based upon the paucity of B cell precursors in the thymus, we wondered whether peripheral B cells enter the thymus in the *steady state*. In order to address this, we intravenously injected bulk splenic B cells into syngeneic hosts. Seven days later, donor B cells were detectable in both spleen and thymus, whereby the relative abundance among host B cells in the thymus was about 5- to 10-fold lower as compared to the spleen. Although at first glance, this suggests that thymic immigration is a fairly efficient process, any comparison of its efficacy in relation to homing to the spleen is blurred by the fact that upon entering the thymus, B cells undergo several cell divisions. The capacity to enter the thymus does not seem to be restricted to any particular activation state, since purified naïve B cells (IgM^+^IgD^+^) also entered the thymus.

Taken together, it is reasonable to assume that both intrathymic B lymphopoesis and immigration of BM-derived B cells contribute to the thymic B cell pool. However, we lack a precise understanding of the relative contribution of either pathway. On the one hand, the virtual absence of pro- and pre-B cells may render intrathymic differentiation an unlikely source of the majority of thymic B cells. On the other hand, thymic B cells in parabiosed mice do not equilibrate to the same extent as is observed for splenic B cells, insinuating a substantial contribution of intrathymic B cell differentiation ([@B10]). Unraveling the lineage relation between peripheral "mainstream" B cells and thymic B cells remains experimentally challenging. Ultimately, this issue is linked to the questions whether thymic B cells display distinct features, and whether these features are manifestations of a hard-wired "thymic B lineage differentiation program" or result from extrinsic cues.

Intrathymic B Cell Licensing {#S3}
============================

The unusual phenotype of thymic B cells {#S3-3}
---------------------------------------

Some phenotypic features (e.g., CD5 expression) had suggested that thymic B cells may be related to the fetal liver-derived B1 lineage ([@B8]). However, whereas *bona fide* B1 cells in the peritoneal cavity are restored only by reconstitution with fetal liver cells, but not BM cells, the thymic B cell pool is efficiently generated from both precursors ([@B10]). Thus, thymic B cells clearly are genealogically related to the B2 "mainstream" B cell lineage.

Unlike resting B cells in spleen and lymph node, thymic B cells express high levels of MHC class II and the co-stimulatory molecules CD80 and CD86 ([@B9]--[@B11]). Moreover, a substantial fraction of thymic B cells have class-switched, whereby the distribution of isotype classes is remarkably stereotypic from mouse to mouse. Perhaps the most unusual feature of thymic B cells is their expression of the autoimmune regulator (Aire) gene. Aire is known to be crucial for "promiscuous gene expression" (pGE) of peripheral self-antigens in medullary thymic epithelial cells (mTECs) ([@B12]). The only cell-type other than mTECs that had so far been reported to express Aire is rare cells in the lymph node which have been termed as extrathymic Aire expressing cells (eTACs) ([@B13]). eTACs are of hematopoietic origin, yet their exact lineage identity remains elusive ([@B14]). Using Aire-reporter mice, we noted a reporter-positive population of non-mTEC cells in the thymus and subsequently identified these cells as thymic B cells ([@B9]). Faithful expression of the Aire-reporter was confirmed by RT-PCR and intracellular protein staining. Aire protein was detectable in nuclear dots in around 2--3% of thymic B cells, whereby protein levels were substantially lower than in mTECs. A comparison of gene expression profiles in WT versus Aire^−/−^ thymic B cells revealed that several hundred genes are differentially expressed. Very few of these had previously been reported to be Aire dependent in mTECs or eTACs, indicating that Aire's function as a transcriptional regulator is cell context dependent. Of note, whereas in mTECs the expression of several thousand genes is modulated by Aire, only a few hundred genes are controlled by Aire in thymic B cells or eTACs. Furthermore, it remains to be established whether Aire-dependent expression of any tissue-restricted antigen in thymic B cells is essential for T cell tolerance.

Are these distinctive features of thymic B cells an inherent feature of B cells that arise through intrathymic B lympopoiesis? To address this question, we followed the fate of i.v. injected IgM^+^IgD^+^ B cells, which are MHCII^intermediate^, CD80^−^ and Aire^−^. Seven days after injection, donor cells in the spleen had retained their initial phenotype. In contrast, cells that had immigrated into the thymus recapitulated all features of *steady state* thymic B cells, indicating that the unique phenotype of thymic B cells is imprinted by extrinsic cues in the thymic microenvironment, and we referred to this microenvironmental programing as "thymic B cell licensing" ([@B9]).

Thymic B cell licensing requires CD40 {#S3-4}
-------------------------------------

The transition from a MHCII^int^CD80^−^Aire^−^stage to a MHCII^hi^CD80^+^Aire^+^ phenotype during thymic B cell licensing is strikingly reminiscent of mTEC "maturation." However, whereas mTEC maturation is orchestrated by RANK signals ([@B15]--[@B17]), thymic B cell licensing crucially requires another TNF family member, CD40. Treatment of splenic B cells with agonist anti-CD40 antibody emulated B cell licensing, including induction of Aire ([@B9]). Thymic B cells in *Cd40*^−/−^ and *Cd40lg*^−/−^ mice are substantially diminished, consistent with a role of CD40 signals in thymic B cell homeostasis ([@B7]). Strikingly, the phenotype of thymic B cells in the absence of CD40 signaling is that of resting peripheral B cells. Thus, distinct signaling axes control the expression of Aire and the acquisition of a MHCII^high^CD80^+^ phenotype in mTECs or thymic B cells.

Cross-talk with autoreactive CD4 T cells regulates thymic B cell numbers and licensing {#S3-5}
--------------------------------------------------------------------------------------

Fujihara et al. showed that thymic B cell numbers are regulated by CD4 single-positive (SP) thymocytes ([@B7]). Similarly, we found that thymic B cells from TCRα^−/−^ mice, which lack SP thymocytes, express low levels of MHCII, are negative for co-stimulatory molecules, do not undergo class-switching and fail to up-regulate Aire ([@B9]). Strikingly, although CD4 SP thymocytes in "monoclonal" OT2 TCR transgenic mice on TCRα^−/−^ background express normal levels of CD40L, B cells in these mice are not licensed, indicating that a polyclonal repertoire of CD4 SP cells is necessary. The requirement for diverse TCRs seems to reflect a critical role of autoreactivity within the nascent CD4 SP compartment. Along these lines, B cell licensing can be mimicked *in vitro* when splenic B cells are pulsed with cognate antigen and co-cultured with specific CD4 SP cells. Moreover, MHCII-deficient B cells do not undergo licensing upon immigration into the thymus. Together, these observations suggest that cognate interactions through direct antigen presentation by B cells provide a platform for CD40 signaling and thereby initiate licensing (Figure [1](#F1){ref-type="fig"}). This tolerogenic feed-forward loop represents a striking parallel to the very similar cross-talk between mTECs and CD4 SP cells that is thought to bolster the tolerogenic features of mTECs ([@B18]).

![**Sequential phases of thymic B cell licensing**. (1) Recirculating peripheral B cells can enter the thymus. Their peptide (p)MHCII ligandome is expected to mostly contain endogenously expressed "resting B cell autoantigens." Whereas the peripheral T cell repertoire is likely to be robustly tolerant toward these self-antigens, the nascent CD4 SP compartment is not (yet) fully purged of the respective specificities. (2) An unknown fraction of "B cell-reactive" CD4 SP cells within the diverse CD4 SP repertoire recognize "resting B cell autoantigens" and provide CD40 signals. CD40L is constitutively expressed by CD4 SP cells regardless of autoreactivity, presumably as a consequence of preceeding positively selecting interactions with cTECs. (3) Cross-talk with CD4 single-positive thymocytes induces proliferation, up-regulation of MHC class II, induction of CD80, induction of Aire, and Ig class-switching. (4) Licensed B cells delete autoreactive CD4 T cells, including TCR specificities that recognize "licensing-dependent" self-antigens; these are expected to include, but are not restricted to, self-antigens that are also up-regulated in activated B cells in the periphery (Type A) and Aire-dependent self-antigens (TRAs) (Type B).](fimmu-06-00376-g001){#F1}

Thymic B Cells and Central T Cell Tolerance {#S4}
===========================================

Evidence for a non-redundant contribution of thymic B cells to central tolerance {#S4-6}
--------------------------------------------------------------------------------

Several studies have shown that thymic B cells can contribute to negative selection under particular experimental conditions. Forced expression of the I-E MHCII molecule exclusively on B cells led to deletion of superantigen reactive T cells ([@B19]). Myelin oligodendrocyte glycoprotein (MOG)-specific CD4^+^ thymocytes were negatively selected when an epitope of MOG was exclusively presented by B cells ([@B20]). Perera et al. used autoreactive B cell receptor (BCR) transgenic mice to show that cognate T cells of the "same specificity" were negatively selected in the thymus ([@B10]). We showed that a "licensing-dependent" neo-antigen selectively up-regulated in immigrating B cells mediated negative selection through direct presentation ([@B9]).

What is known about the overall contribution of thymic B cells to central T cell tolerance? In mice lacking B cells, the size of the CD4SP cell compartment is significantly increased ([@B9], [@B21]). This resembles previous observations in mice that either lacked DCs or had a diminution of MHCII on mTECs, suggesting a non-redundant contribution of thymic B cells to negative selection of CD4 T cells ([@B22], [@B23]). Other recent reports showed that thymic Treg cells are decreased in B cell-deficient mice, and increased Treg numbers were observed in the thymus of Baff-transgenic mice harboring elevated B cell numbers ([@B21], [@B24]). Although these findings support a role of thymic B cell for central tolerance induction under physiological conditions, the exact spectrum of self-antigens that may require such a contribution remains to be characterized.

Do thymic B cells pre-empt the self-antigen signature of germinal center B cells? {#S4-7}
---------------------------------------------------------------------------------

The role of CD40 and the cognate interactions between B cells and CD4 T cells during thymic B cell licensing are reminiscent of the germinal center (GC) reaction ([@B25]). Indeed, a substantial fraction of thymic B cells display a Fas^+^GL7^+^ phenotype that is otherwise characteristic for GC B cells ([@B9]). It is therefore tempting to speculate that the tolerogenic potential of licensed thymic B cells might in particular comprise "activated-B-cell" autoantigens. Consistent with that idea, CD4 SP thymoctes from B cell-deficient mice are hyper-responsive to CD40-activated B cells ([@B9]). A central assumption of the GC paradigm is that CD4 T cell help needs to be tightly focused on epitopes of the foreign antigen that has been internalized via the BCR ([@B26]). In order to control BCR--hypermutation-related neo-autoreactivity among GC B cells, self-reactive B cells need to be deprived from cognate help. This not only requires robust CD4 T cell tolerance toward exogenously derived self-determinants that have been captured via the hypermutated BCR but also that the CD4 T cell repertoire is efficiently purged of reactivity toward any endogenously derived B cell autoantigen that is concurrently presented. Because thymic B cells may emulate the peptide/MHC composition of GC B cells in a tolerogenic setting, thymic B cell licensing may pre-empt T cell recognition of "activated B cell autoantigens" in an inflammatory context in secondary lymphoid tissues.

A role for the BCR? {#S4-8}
-------------------

B cells efficiently present antigens that have been captured via the BCR ([@B27]). So, do BCR-specificity and/or -autoreactivity play a role in thymic B cell licensing and B cell-mediated central tolerance? Using BCR knock-in and T cell receptor transgenic mice specific for the same antigen, Perera et al. elegantly demonstrated that autoreactive B cells are particularly efficient APCs to induce negative selection of T cells with identical specificity ([@B10]). However, we found no evidence that BCR autoreactivity may favor B cell entry into the thymus or is a prerequisite to subsequently undergo licensing ([@B9]). Specifically, we employed SW~HEL~ mice to address these issues. In these mice, around two-thirds of peripheral B cells express a transgenic "anti-foreign BCR" specific for hen egg lysozyme (HEL), whereas the remainder of B cells carry endogenously rearranged BCRs, some of which may harbor autoreactivity. The relative abundance of HEL^+^ B cells in the thymus exactly reflected their peripheral frequency, and both HEL^+^ and HEL^−^ B cells underwent intrathymic licensing. Future work is needed to more conclusively address the composition of the thymic B cell repertoire, for instance, through BCR sequencing.

Open Questions {#S5}
==============

Is BCR class-switching in the thymus physiologically relevant? {#S5-9}
--------------------------------------------------------------

As a consequence of licensing, thymic B cells class-switch to IgG or IgA. It is therefore conceivable that thymic B cells present B lineage-specific "neo-epitopes" generated through isotype-class-switching or possibly also somatic hypermutation. In all likelihood, and in distinction from the GC reaction, class-switching in the thymus may occur "spontaneously," i.e., independent of cognate help downstream of BCR-mediated antigen capture. This has obvious implications for the emergence of "natural" Igs. Some thymic B cells display a memory B cell phenotype (CD38^+^Fas^lo^), and it is possible that IgG- or IgA-positive thymic B cells re-enter the blood stream. In fact, we observed a minute population of class-switched donor cell in the periphery after intrathymic injection of naive B cells (Tomoyoshi Yamano and Ludger Klein unpublished). More work is needed to clarify the role of the thymus as a potential source of natural Igs.

Do thymic B cells shape the thymic microenvironment? {#S5-10}
----------------------------------------------------

It was shown that thymic B cells express Ltα and Ltβ, and thereby regulate mTEC cellularity ([@B28]). Thymic B cells also express a variety of cytokines and chemokines, e.g., IL-10, IL-12, IL-16, and CCL22 (Tomoyoshi Yamano and Ludger Klein unpublished). These data suggest additional layers of cross-talk in the thymus. However, more work is needed to better understand whether and how thymic B cells may organize the thymic microenvironment.

Do thymic B cells play a role in human disease? {#S5-11}
-----------------------------------------------

The presence of B cells with an "activated" phenotype in the healthy human thymus has long been recognized ([@B29]), but their origin and specificity has remained elusive. Ectopic GC-like structures are present in thymi of early-onset myasthenia gravis (MG) patients, and it was hypothesized that they are the site of auto-sensitization against the acetylcholine receptor (AChR) ([@B30]). However, a recent characterization of antibody repertoires in MG thymi revealed expansion of a polyclonal repertoire unrelated to AChR specificities ([@B31]). Thus, it remains to be shown whether the accumulation of B cells in MG thymi is a cause or a consequence of disease.
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